Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
Health Care
pmn
ProMIS Neurosciences
NASDAQ: PMN
0.00 (+0.52%)
0.7751
USD
At close at Aug 01, 20:43 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

ProMIS Neurosciences: Pivotal Mining Note Revolutionizes Cryptocurrency Investment Landscape

3 days ago
publisher logo
Cashu

ProMIS Neurosciences: Pioneering Innovative Treatments for Alzheimer's and Neurodegenerative Disorders

5 days ago

Latest ProMIS Neurosciences News

prnewswire.com

PMN Hits $1M in Pre-Sales -- A Compliant Way to Accumulate Bitcoin Over Time

5 days ago
finance.yahoo.com

ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now

Feature Image for interests on Bank Of Canada, Canadian Stocks, ETF, Earnings Reports from finance.yahoo.com
10 months ago
finance.yahoo.com

ProMIS Neurosciences to Showcase PMN310’s Ability to Target Toxic Oligomers and Distinguish from Other Amyloid-Beta Oligomers in Preclinical Studies at the 4th International Conference on Cognitive & Behavioral Neurosciences

Feature Image for interests on Ad, Alzheimer’S Disease, Antibody Therapeutics, Healthcare from finance.yahoo.com
11 months ago
finance.yahoo.com

ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Feature Image for interests on Biotechnology Company, Cambridge, Healthcare, Massachusetts from finance.yahoo.com
11 months ago
finance.yahoo.com

GMG Provides Commercialisation Update on Energy Savings Coating THERMAL-XR(R)

Feature Image for interests on Australia, Gmg, Gmg Graphene, Graphene Manufacturing Group Ltd. from finance.yahoo.com
12 months ago
finance.yahoo.com

ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights

Feature Image for interests on Alzheimer’S Disease, Amyloid Beta, Amyotrophic Lateral Sclerosis, Antibody Therapeutics from finance.yahoo.com
12 months ago
finance.yahoo.com

ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024

Feature Image for interests on Antibody Therapeutics, Biotechnology Company, Btig Virtual Biotechnology Conference, Chief Medical Officer from finance.yahoo.com
about 1 year ago
finance.yahoo.com

ProMIS Neurosciences Showcases Novel Vaccine Approach for Maximal Targeting of Toxic Amyloid-Beta Oligomers at the 2024 Alzheimer’s Association International Conference

Feature Image for interests on Alzheimer’S Disease, Antibody Therapeutics, Association International Conference, Healthcare from finance.yahoo.com
about 1 year ago
finance.yahoo.com

Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfoliowith Agreement to Acquire Human Immunology Biosciences

Feature Image for interests on Biogen, Clinical Studies, Global Development, Healthcare from finance.yahoo.com
about 1 year ago
benzinga.com

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Feature Image for interests on Adil, Aeye, Athe, Basic Materials from benzinga.com
over 1 year ago
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.